Allspring Global Investments Portfolio holdings
AUM
$59.8B
1-Year Return
21.41%
This Quarter Return
-13.84%
1 Year Return
+21.41%
3 Year Return
+84.27%
5 Year Return
–
10 Year Return
–
AUM
$59.9B
AUM Growth
-$19.4B
(-24%)
Cap. Flow
-$6.77B
Cap. Flow
% of AUM
-11.31%
Top 10 Holdings %
Top 10 Hldgs %
12.9%
Holding
3,093
New
67
Increased
555
Reduced
1,970
Closed
398
Top Buys
| 1 |
Vulcan Materials
VMC
|
+$197M |
| 2 |
Charles River Laboratories
CRL
|
+$131M |
| 3 |
Rollins
ROL
|
+$58.6M |
| 4 |
Tetra Tech
TTEK
|
+$52.2M |
| 5 |
Axalta
AXTA
|
+$48.5M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$330M |
| 2 |
Amazon
AMZN
|
+$225M |
| 3 |
Apple
AAPL
|
+$222M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$202M |
| 5 |
Meta Platforms (Facebook)
META
|
+$134M |
Sector Composition
| 1 | Technology | 18.32% |
| 2 | Industrials | 12.73% |
| 3 | Healthcare | 12.42% |
| 4 | Consumer Discretionary | 11.91% |
| 5 | Financials | 11.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Conduent
CNDT
$458M
| $126K | ﹤0.01% |
29,207
-153,834
| -84% | -$664K |
|
1977
Harmony Biosciences
HRMY
$1.92B
| $126K | ﹤0.01% |
2,603
-9,531
| -79% | -$461K |
|
1978
BioCryst Pharmaceuticals
BCRX
$1.69B
| $125K | ﹤0.01% |
11,822
-118,438
| -91% | -$1.25M |
|
1979
Cullinan Oncology
CGEM
$382M
| $125K | ﹤0.01% |
9,760
+168
| +2% | +$2.15K |
|
1980
O-I Glass
OI
$1.95B
| $125K | ﹤0.01% |
8,952
-98,264
| -92% | -$1.37M |
|
1981
TTM Technologies
TTMI
$4.99B
| $125K | ﹤0.01% |
10,046
-76,427
| -88% | -$951K |
|
|
ECOM
1982
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $125K | ﹤0.01% |
8,606
-44,713
| -84% | -$649K |
|
1983
Yelp
YELP
$1.97B
| $124K | ﹤0.01% |
4,496
-34,592
| -88% | -$954K |
|
|
BBT
1984
Beacon Financial Corporation
BBT
$2.2B
| $124K | ﹤0.01% |
5,027
-25,147
| -83% | -$620K |
|
1985
Dycom Industries
DY
$7.51B
| $124K | ﹤0.01% |
1,337
-11,031
| -89% | -$1.02M |
|
1986
Bloom Energy
BE
$15.7B
| $122K | ﹤0.01% |
7,415
-32,688
| -82% | -$538K |
|
1987
Constellium
CSTM
$2.09B
| $122K | ﹤0.01% |
9,249
-51,933
| -85% | -$685K |
|
1988
Eagle Bancorp
EGBN
$596M
| $122K | ﹤0.01% |
2,580
-12,488
| -83% | -$591K |
|
1989
Entegris
ENTG
$12.6B
| $122K | ﹤0.01% |
1,332
-13,956
| -91% | -$1.28M |
|
|
TPTX
1990
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $122K | ﹤0.01% |
1,628
-553,344
| -100% | -$41.5M |
|
1991
Americold
COLD
$3.76B
| $121K | ﹤0.01% |
4,058
-27,347
| -87% | -$815K |
|
1992
Nuveen Taxable Municipal Income Fund
NBB
$477M
| $121K | ﹤0.01% |
6,817
| – | – |
|
1993
Clearwater Paper
CLW
$342M
| $120K | ﹤0.01% |
3,591
+2,550
| +245% | +$85.2K |
|
1994
Lands' End
LE
$454M
| $120K | ﹤0.01% |
11,339
-28,552
| -72% | -$302K |
|
1995
Kymera Therapeutics
KYMR
$3.3B
| $119K | ﹤0.01% |
6,062
-15,134
| -71% | -$297K |
|
1996
Ultragenyx Pharmaceutical
RARE
$3.01B
| $119K | ﹤0.01% |
1,998
-435
| -18% | -$25.9K |
|
1997
United Bankshares
UBSI
$5.36B
| $119K | ﹤0.01% |
3,417
-37,166
| -92% | -$1.29M |
|
1998
Zymeworks
ZYME
$1.15B
| $119K | ﹤0.01% |
22,520
+4,226
| +23% | +$22.3K |
|
|
SPWR
1999
DELISTED
SunPower Corporation Common Stock
SPWR
| $119K | ﹤0.01% |
7,541
-31,761
| -81% | -$501K |
|
2000
N-able
NABL
$1.53B
| $118K | ﹤0.01% |
13,144
-180,542
| -93% | -$1.62M |
|